GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » Cyclically Adjusted FCF per Share

Harbin Pharmaceutical Group Co (SHSE:600664) Cyclically Adjusted FCF per Share : ¥0.25 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Harbin Pharmaceutical Group Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.113. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.25 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Harbin Pharmaceutical Group Co's average Cyclically Adjusted FCF Growth Rate was 13.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -5.30% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Harbin Pharmaceutical Group Co was 46.50% per year. The lowest was -20.60% per year. And the median was 8.10% per year.

As of today (2024-06-13), Harbin Pharmaceutical Group Co's current stock price is ¥2.78. Harbin Pharmaceutical Group Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.25. Harbin Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF of today is 11.12.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Harbin Pharmaceutical Group Co was 54.45. The lowest was 10.09. And the median was 17.10.


Harbin Pharmaceutical Group Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Harbin Pharmaceutical Group Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Pharmaceutical Group Co Cyclically Adjusted FCF per Share Chart

Harbin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.17 0.19 0.21 0.26

Harbin Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.20 0.23 0.26 0.25

Competitive Comparison of Harbin Pharmaceutical Group Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Harbin Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF falls into.



Harbin Pharmaceutical Group Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Harbin Pharmaceutical Group Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.113/115.2271*115.2271
=-0.113

Current CPI (Mar. 2024) = 115.2271.

Harbin Pharmaceutical Group Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.271 98.200 0.318
201409 0.094 98.900 0.110
201412 0.006 99.000 0.007
201503 -0.104 99.900 -0.120
201506 0.111 99.500 0.129
201509 0.259 100.500 0.297
201512 0.313 100.600 0.359
201603 0.413 102.200 0.466
201606 0.337 101.400 0.383
201609 0.125 102.400 0.141
201612 0.183 102.600 0.206
201703 0.034 103.200 0.038
201706 0.063 103.100 0.070
201709 -0.077 104.100 -0.085
201712 -0.001 104.500 -0.001
201803 0.057 105.300 0.062
201806 -0.025 104.900 -0.027
201809 0.020 106.600 0.022
201812 0.205 106.500 0.222
201903 -0.075 107.700 -0.080
201906 -0.009 107.700 -0.010
201909 0.012 109.800 0.013
201912 -0.042 111.200 -0.044
202003 -0.008 112.300 -0.008
202006 -0.073 110.400 -0.076
202009 0.025 111.700 0.026
202012 -0.283 111.500 -0.292
202103 -0.068 112.662 -0.070
202106 0.149 111.769 0.154
202109 -0.114 112.215 -0.117
202112 -0.018 113.108 -0.018
202203 0.049 114.335 0.049
202206 -0.004 114.558 -0.004
202209 -0.011 115.339 -0.011
202212 0.180 115.116 0.180
202303 0.068 115.116 0.068
202306 0.122 114.558 0.123
202309 0.127 115.339 0.127
202312 0.037 114.781 0.037
202403 -0.113 115.227 -0.113

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Harbin Pharmaceutical Group Co  (SHSE:600664) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Harbin Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=2.78/0.25
=11.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Harbin Pharmaceutical Group Co was 54.45. The lowest was 10.09. And the median was 17.10.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Harbin Pharmaceutical Group Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Pharmaceutical Group Co (SHSE:600664) Business Description

Traded in Other Exchanges
N/A
Address
Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018
Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.
Executives
Lin Guo Ren senior management
Wang Hai Sheng senior management
Liu Bo senior management
Meng Xiao Dong senior management
Xu Hai Ying Directors, senior managers
Liang Chen senior management
Wang Peng Hao senior management
Xiao Qiang senior management
Wei Shuang Ying senior management
Zhou Xing senior management
Bian Ke Supervisors
Sha Mei senior management
Jian Shi Hui Zhu Xi Supervisors
Wang Zhi Fu Supervisors
Jiang Lu Director

Harbin Pharmaceutical Group Co (SHSE:600664) Headlines

No Headlines